Table 3.
Odds ratios relating outcome to COV50.
| Outcome | Number E/R | Odds ratio (95% confidence interval) | p value |
|---|---|---|---|
| Mortality | 23/228 | ||
| Unadjusted | 3.52 (2.02–6.13) | <0.0001 | |
| Adjusted | |||
| Sex and age | 3.23 (1.81–5.74) | <0.0001 | |
| + timepoint 1 WHO score | 2.63 (1.21–5.69) | 0.014 | |
| + body mass index and comorbidities | 2.73 (1.25–5.95) | 0.012 | |
| Progressing WHO score | 48/228 | ||
| Unadjusted | 2.63 (1.80–3.85) | <0.0001 | |
| Adjusted | |||
| Sex and age | 2.37 (1.58–3.54) | <0.0001 | |
| + timepoint 1 WHO score | 3.34 (1.83–6.07) | <0.0001 | |
| + body mass index and comorbidities | 3.38 (1.85–6.17) | <0.0001 |
Number E/R indicates the number of events/number at risk. Odds ratios express the risk for 1-SD increment in COV50. Comorbidities include hypertension, heart failure, diabetes and cancer.